Price To Earnings Ratio 24.13 | Sector PE 71.63 |
PB Ratio 3.23 | Sector PB 9.22 |
EPS 18.65 | Dividend Yield 0.23 |
Today's Volume 71.557 K | 5 Day Avg. Volume 119.369 K |
PEG Ratio 6.32 | Market Cap. ₹ 4,210.00 Cr. |
Time | AARTIDRUGS | VS | Industry |
---|---|---|---|
1 Day | 0.6% | -1.57% | |
1 Week | -0.39% | -0.71% | |
1 Month | -6.55% | -0.68% | |
6 Months | 2.31% | 19.22% | |
1 Year | 1.03% | 40.44% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 449.21 | Bullish |
20 | 455.75 | Bearish |
30 | 463.07 | Bearish |
50 | 477.53 | Bearish |
100 | 498.94 | Bearish |
200 | 478.82 | Bearish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 358.92 | 133.32 | 70.41 | 154.95 | |||||
Investing Activities | -223.65 | -163.97 | -149.64 | -71.78 | |||||
Financing Activities | -136.03 | 16.54 | 92.02 | -81.13 | |||||
Net Cash Flow | -0.76 | -14.11 | 12.80 | 2.04 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Aarti Drugs | 0.6 | -0.39 | -6.55 | 2.31 | 1.03 |
Alembic | -0.87 | 4.08 | 1.29 | 2.51 | 2.51 |
Aurobindo Pharma | 1.41 | -0.57 | -10.08 | -10.84 | 14.22 |
Fortis Healthcare | 2.64 | 7.72 | 17.12 | 47.18 | 78.55 |
Ajanta Pharmaceuticals | -1.34 | -5.51 | -8.71 | 12.47 | 38.64 |
Aarti Drugs Limited is an Indian pharmaceutical company that manufactures active ingredients (APIs), pharmaceutical intermediates and specialty chemicals. The company focuses on manufacturing products through its wholly owned subsidiary Pinnacle Life Science Private Limited. The company's API products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin. Its pharmaceutical intermediates include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemicals such as benzenesulfonyl chloride and methyl nicotinate. The company's products under development include the treatment of alcoholism, anticoagulants, hyperphosphatemia, cholesterol, cardiovascular diseases, cardioprotective agents and diabetes drugs.